Table of Contents
PPT Slide
PTSD: Learning Objectives
Posttraumatic Stress Disorder (PTSD): Prevalence and Risks
Lifetime Prevalence of Trauma and Probability of Developing PTSD
Factors Increasing Vulnerability to PTSD
Neurobiology of PTSD
PTSD Diagnostic Criteria
PTSD Diagnostic Criteria: Reexperiencing
PTSD Diagnostic Criteria: Avoidance and Numbing
PTSD Diagnostic Criteria: Increased Arousal
Recognizing PTSD in Clinical Practice
Somatic Presentation of PTSD
Comorbidity of PTSD With Other Psychiatric Disorders
Medical/Psychiatric Comorbidity With PTSD
Functional Impairment With PTSD
Improving Detection of PTSD
Talking to Patients About PTSD
Talking to Patients About PTSD (cont.)
Education and Counseling in PTSD
Education and Counseling in PTSD (cont.)
Psychological Treatments for PTSD
Cognitive-Behavioral Treatments for PTSD
Anxiety Management in PTSD
Pharmacologic Treatment of PTSD
Antidepressant Placebo-Controlled Trials in PTSD
Global Severity of PTSD: Fluoxetine vs Placebo
Sertraline vs Placebo PTSD Studies: Mean CAPS-2 Score
Sertraline Efficacy in PTSD
Quality of Life in PTSD: Sertraline vs Placebo
Improvement in Stress Vulnerability: Fluoxetine vs Placebo
Open-Label Trials in PTSD
Pharmacologic Treatment of PTSD: Recommendations
PTSD: Summary
PPT Slide
|